Cited by 35Influenza Virus Research StudiesImmune responses and vaccinationsT-cell and B-cell Immunology

Quantity, not quality, of antibody response decreased in the elderly

Open access
Blomberg, Bonnie B., Frasca, Daniela·2011·Journal of Clinical Investigation

Abstract

The burden of disease during seasonal influenza epidemics is felt most keenly among the very young and the elderly. Although vaccination effectively protects children and young adults against infection, it has limited efficacy in elderly individuals. This has been linked to a reduced ability to induce a robust serum antibody response. In this issue of the JCI, Sasaki et al. identify some of the cellular and molecular deficits that underlie the reduced serum antibody response induced by influenza vaccination in elderly individuals. Importantly, they show that it is the quantity of the response, and not its quality, that needs to be improved if we are to enhance the success of influenza vaccination in this vulnerable population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci58406

Cites

20 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Werdnig G. Zwei Frühinfantile hereditäre Fälle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber auf neurotischer Grundlage. Arch Psychiat Nervenkr. 1891;22(2):437-480.
  2. Hoffman J. Ueber chronische spinale Muskelatro- phie im Kindesalter, auf Familiärer Basis. Beutsch Z Nervenheilk. 1893;3(6):427-470.
  3. Lefebvre S, et al. Identification and characteriza- tion of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155-165.
  4. Wan L, et al. The survival of motor neurons pro- tein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol Cell Biol. 2005;25(13):5543-5551.
  5. Feldkotter M, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70(2):358-368.
  6. Mailman MD, et al. Molecular analysis of spinal muscular atrophy and modification of the pheno- type by SMN2. Genet Med. 2002;4(1):20-26.
  7. Rochette CF, Gilbert N, Simard LR. SMN gene duplication and the emergence of the SMN2 gene occurred in unique hominids: SMN2 is unique to Homo sapiens. Hum Genet. 2001;108(3):255-266.
  8. Monani UR, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8(7):1177-1183.
  9. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splic- ing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1998;96(11):6307-6311.
  10. Fischer U, Liu Q, Dreyfuss G. The SMN-SIP1 com- plex has an essential role in spliceosomal snRNP biogenesis. Cell. 1997;90(6):1023-1029.
  11. Brichta L, et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential ther- apy for spinal muscular atrophy. Hum Mol Genet. 2003;12(19):2481-2489.
  12. Andreassi C, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet. 2004; 12(1):59-65.
  13. Grzeschik SM, et al. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol. 2005;58(2):194-202.
  14. Brichta L, et al. In vivo activation of SMN in spi- nal muscular atrophy carriers and patients treated with valproate. Ann Neurol. 2006;59(6):970-975.
  15. Brahe C, et al. Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet. 2005;13(2):256-259.
  16. Avila AM, et al. Trichostatin A increases SMN expres- sion and survival in a mouse model of spinal muscu- lar atrophy. J Clin Invest. 2007;117(3):659-671.

Cited by

Sorted by citations

Authors
Blomberg, B. B., & Frasca, D.
Venue
Journal of Clinical Investigation
Published
2011-08-01
Volume
121
Issue
8
Pages
2981-2983
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2012151374
Cited by
34
References
20
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 5
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • FightSMA
  • National Institutes of Health (NICHD‐R01)
  • National Institute on Aging (R01AG032576, R37AG023717, AG32576, AG23717, R56AG032576)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
influenza vaccination, older adults, serum antibody response, antibody quality, vaccine efficacy, immunosenescence
MeSH terms
Aged, Antibodies, Antibody Formation, Communicable Disease Control, Geriatrics, Humans, Influenza, Human, Influenza Vaccines, Vaccination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review